pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia

Journal of Molecular Biology

Volumn 333, Issue 5, 2003, Pages 1003-1023

  Srinivasan, Rekha ^a   Jones, Eric M ^b   Liu, Keqian ^a   Ghiso, Jorge ^c   Marchant, Roger E ^b   Zagorski, Michael G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Case Western Reserve University   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid; Amyloidogenesis; British; Fibril; Structure

Indexed keywords

AMYLOID; CONGO RED; PEPTIDE; PEPTIDE ABRI; THIOFLAVINE; UNCLASSIFIED DRUG;

ACIDITY; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; COVALENT BOND; DEMENTIA; ELECTRON MICROSCOPY; FAMILIAL BRITISH DEMENTIA; FLUORESCENCE SPECTROSCOPY; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; RANDOMIZATION; SOLUBILITY;

EID: 0142247606     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.09.001     Document Type: Article

References (90)

1. Lansbury P.T., Kosik K.S. Neurodegeneration: new clues on inclusions. Chem. Biol. 7:2000;R9-R12.
2. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. Roy. ser. B. 356:2001;133-145.
3. Temussi P.A., Masino L., Pastore A. From Alzheimer to Huntington: why is a structural understanding so difficult? EMBO J. 22:2003;355-361.
4. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., et al. Amyloid fibril protein nomenclature. Amyloid. 9:2002;197-200.
5. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA. 96:1999;3590-3594.
6. Takahashi Y., Ueno A., Mihara H. Mutational analysis of designed peptides that undergo structural transition from alpha helix to beta sheet and amyloid fibril formation. Struct. Fold. Des. 8:2000;915-925.
7. Inouye H., Fraser P.E., Kirschner D.A. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: analysis by X-ray diffraction. Biophys. J. 64:1993;502-519.
8. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273:1997;729-739.
9. Benzinger T.L., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., Meredith S.C. Two-dimensional structure of beta-amyloid(10-35) fibrils. Biochemistry. 39:2000;3491-3499.
10. Bouchard M., Zurdo J., Nettleton E.J., Dobson C.M., Robinson C.V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9:2000;1960-1967.
11. Egnaczyk G.F., Greis K.D., Stimson E.R., Maggio J.E. Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits. Biochemistry. 40:2001;11706-11714.
12. LeVine H. Thioflavine T interaction with amyloid β-sheet structures. Amyloid: Int. J. Expt. Clin. Invest. 2:1995;1-6.
13. Klunk W.E., Jacob R.F., Mason R.P. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309:1999;285-305.
14. Haass C., Steiner H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nature Neurosci. 4:2001;859-860.
15. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
16. Hirakura Y., Yiu W., Yamamoto A., Kagan B. Amyloid peptide channels: blockade by zinc and inhibition by Congo red (amyloid channel block). Amyloid: Int. J. Expt. Clin. Invest. 7:2000;194-199.
17. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:2002;507-511.
18. Plant G.T., Revesz T., Barnard R.O., Harding A.E., Gautier-Smith P.C. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain. 113:1990;721-747.
19. Vidal R., Frangione B., Rostagno A., Mead S., Revesz T., Plant G., Ghiso J. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature. 399:1999;776-781.
20. Ghiso J., Holton J., Miravalle L., Calero M., Lashley T., Vidal R., et al. Systemic amyloid deposits in familial British dementia. J. Biol. Chem. 276:2001;43909-43914.
21. Kim S.H., Wang R., Gordon D.J., Bass J., Steiner D.F., Lynn D.G., et al. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nature Neurosci. 2:1999;984-988.
22. Mori H., Takio K., Ogawara M., Selkoe D.J. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J. Biol. Chem. 267:1992;17082- 17086.
23. Tekirian T.L., Saido T.C., Markesbery W.R., Russell M.J., Wekstein D.R., Patel E., Geddes J.W. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J. Neuropathol. Expt. Neurol. 57:1998;76-94.
24. El-Agnaf O.M., Sheridan J.M., Sidera C., Siligardi G., Hussain R., Haris P.I., Austen B.M. Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia. Biochemistry. 40:2001;3449-3457.
25. Lelyveld V., El-Agnaf O.M., Siligardi G., Hussain R., Haris P.I., Lee M., Austen B. Conformational analysis of peptides derived from the BRI gene. Spectroscopy. 15:2001;129-139.
26. El-Agnaf O.M., Nagala S., Patel B.P., Austen B.M. Non-fibrillar oligomeric species of the amyloid ABri Peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J. Mol. Biol. 310:2001;157-168.
27. Zagorski M.G., Yang J., Shao H., Ma K., Zeng H., Hong A. Methodological and chemical factors affecting amyloid β-peptide amyloidogenicity. Wetzel R. Amyloid, Prions, and Other Protein Aggregates. vol. 309:1999;189-204 Academic Press, New York.
28. Shen C.-L., Murphy R.M. Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69:1995;640-651.
29. Fezoui Y., Hartley D., Harper J., Khurana R., Walsh D., Condron M., et al. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments. Amyloid: Int. J. Expt. Clin. Invest. 7:2000;166-178.
30. Wu S.L., Leung D., Tretyakov L., Hu J., Guzzetta A., Wang Y.J. The formation and mechanism of multimerization in a freeze-dried peptide. Int. J. Pharmacol. 200:2000;1-16.
31. Middleton R.E., Warren V.A., Kraus R.L., Hwang J.C., Liu C.J., Dai G., et al. Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry. 41:2002;14734-14747.
32. Costantino H.R., Langer R., Klibanov A.M. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J. Pharm. Sci. 83:1994;1662-1669.
33. Darby N., Creighton T.E. Probing protein folding and stability using disulfide bonds. Mol. Biotechnol. 7:1997;57-77.
34. Kheterpal I., Williams A., Murphy C., Bledsoe B., Wetzel R. Structural features of the Aβ amyloid fibril elucidated by limited proteolysis. Biochemistry. 40:2001;11757-11767.
35. Keller B.O., Li L. Discerning matrix-cluster peaks in matrix-assisted laser desorption/ionization time-of-flight mass spectra of dilute peptide mixtures. J. Am. Soc. Mass Spectrom. 11:2000;88-93.
36. Glocker M.O., Arbogast B., Deinzer M.L. Characterization of disulfide linkages and disulfide bond scrambling in recombinant human macrophage-colony- stimulating factor by fast-atom-bombardment mass-spectrometry of enzymatic digests. J. Am. Soc. Mass Spectrom. 6:1995;638-643.
37. Wood S.J., Maleeff B., Hart T., Wetzel R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J. Mol. Biol. 256:1996;870-877.
38. Greenfield N., Fasman G.D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry. 8:1969;4108-4116.
39. Woody R.W. Nakanishi K., Berova N., Woody R.W. Circular dichroism of peptides and proteins. Circular Dichroism, Principles and Applications. 1994;473-496 VCH Publishers, New York. chapt. 17.
40. Barrow C.J., Yasuda A., Kenny P.T.M., Zagorski M.G. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225:1992;1075-1093.
41. Shi Z., Olson C.A., Rose G.D., Baldwin R.L., Kallenbach N.R. II. Polyproline structure in a sequence of seven alanine residues. Proc. Natl Acad. Sci. USA. 99:2002;9190-9195.
42. Kudva Y.C., Hiddinga H.J., Butler P.C., Mueske C.S., Eberhardt N.L. Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Letters. 416:1997;117-121.
43. Petrosian S.A., Makhatadze G.I. Contribution of proton linkage to the thermodynamic stability of the major cold-shock protein of Escherichia coli CspA. Protein Sci. 9:2000;387-394.
44. Snyder S.W., Ladror U.S., Wade W.S., Wang G.T., Barrett L.W., Matayoshi E.D., et al. Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1994;1216-1228.
45. Perrin D.D. Buffers of low ionic strength for spectrophotometric pK determinations. Aust. J. Chem. 16:1963;572-578.
46. Ding T.T., Harper J.D. Wetzel R. Analysis of amyloid-β assemblies using tapping mode atomic force microscopy under ambient conditions. Amyloid, Prions, and Other Protein Aggregates. vol. 309:1999;510-525 Academic Press, New York.
47. Marchant R.E., Kang I., Sit P.S., Zhou Y., Todd B.A., Eppell S.J., Lee I. Molecular views and measurements of hemostatic processes using atomic force microscopy. Curr. Protein Pept. Sci. 3:2002;249-274.
48. Bustamante C., Keller D. Scanning force microscopy in biology. Phys. Today. 48:1995;32-39.
49. Stine W.B. Jr, Dahlgren K.N., Krafft G.K., LaDu M.J. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278:2003;11612-11622.
50. Harper J.D., Lieber C.M., Lansbury P.T. Jr. Jr Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4:1997;951-959.
51. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
52. Chamberlain A.K., MacPhee C.E., Zurdo J., Morozova-Roche L.A., Hill H.A., Dobson C.M., Davis J.J. Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys. J. 79:2000;3282-3293.
53. Wood S.J., Chan W., Wetzel R. Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry. 35:1996;12623-12628.
54. Serpell L.C., Sunde M., Blake C.C. The molecular basis of amyloidosis. Cell. Mol. Life Sci. 53:1997;871-887.
55. Rochet J.C., Lansbury P.T. Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:2000;60-68.
56. Rostagno A., Revesz T., Lashley T., Tomidokoro Y., Magnotti L., Braendgaard H., et al. Complement activation in chromosome 13 dementias: similarities with Alzheimer's disease. J. Biol. Chem. 277:2002;49782-49790.
57. Mahadevan D., Chattopadhyay T., Palmer R.A., O'Brien R., Saldanha J.W. Predicted fold for the ABri amyloid subunit: a model for amyloidogenesis in familial British dementia. Protein Pept. Letters. 8:2001;171-178.
58. McParland V.J., Kad N.M., Kalverda A.P., Brown A., Kirwin-Jones P., Hunter M.G., et al. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry. 39:2000;8735-8746.
59. Ratnaswamy G., Koepf E., Bekele H., Yin H., Kelly J.W. The amyloidogenicity of gelsolin is controlled by proteolysis and pH. Chem. Biol. 6:1999;293-304.
60. Rostagno A., Vidal R., Kaplan B., Chuba J., Kumar A., Elliott J.I., et al. pH-Dependent fibrillogenesis of a VkappaIII Bence Jones protein. Br. J. Haematol. 107:1999;835-843.
61. Chiti F., Bucciantini M., Capanni C., Taddei N., Dobson C.M., Stefani M. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain. Protein Sci. 10:2001;2541-2547.
62. Koga T., Taguchi K., Kinoshita T., Higuchi M. pH-Regulated formation of amyloid-like beta-sheet assemblies from polyglutamate grafted polyallylamine. Chem. Commun. (Camb.). 2002;242-243.
63. Lai Z., Colón W., Kelly J.W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 35:1996;6470-6482.
64. Hoyer W., Antony T., Cherny D., Heim G., Jovin T.M., Subramaniam V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322:2002;383-393.
65. Alonso D.O., DeArmond S.J., Cohen F.E., Daggett V. Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc. Natl Acad. Sci. USA. 98:2001;2985-2989.
66. Zurdo J., Guijarro J.I., Jimenez J.L., Saibil H.R., Dobson C.M. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. J. Mol. Biol. 311:2001;325-340.
67. Alexandrescu A.T., Rathgeb-Szabo K. An NMR investigation of solution aggregation reactions preceding the missassembly of acid-denatured cold shock protein A into fibrils. J. Mol. Biol. 291:1999;1191-1206.
68. Khurana R., Gillespie J.R., Talapatra A., Minert L.J., Ionescu-Zanetti C., Millett I., Fink A.L. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry. 40:2001;3525-3535.
69. Kad N.M., Thomson N.H., Smith D.P., Smith D.A., Radford S.E. β(2)-Microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J. Mol. Biol. 313:2001;559-571.
70. Tjernberg L.O., Pramanik A., Bjorling S., Thyberg P., Thyberg J., Nordstedt C., et al. Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem. Biol. 6:1999;53-62.
71. Zhu M., Souillac P.O., Ionescu-Zanetti C., Carter S.A., Fink A.L. Surface-catalyzed amyloid fibril formation. J. Biol. Chem. 277:2002;50914-50922.
72. Kelly J.W. The environmental dependency of protein folding best explains prion and amyloid diseases. Proc. Natl Acad. Sci. USA. 95:1998;930-932.
73. Chiti F., De Lorenzi E., Grossi S., Mangione P., Giorgetti S., Caccialanza G., et al. A partially structured species of beta2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J. Biol. Chem. 276:2001;46714-46721.
74. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., Teplow D.B. Amyloid β-protein fibrillogenesis. J. Biol. Chem. 272:1997;22364-22372.
75. Jimenez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C.M., Sunde M., Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18:1999;815-821.
76. Goldsbury C., Kistler J., Aebi U., Arvinte T., Cooper G.J. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285:1999;33-39.
77. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nature Med. 4:1998;1318-1320.
78. Holton J.L., Ghiso J., Lashley T., Rostagno A., Guerin C.J., Gibb G., et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am. J. Pathol. 158:2001;515-526.
79. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., et al. Assembly and aggregational properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
80. Narang H.K. High-resolution electron microscopic analysis of the amyloid fibril in Alzheimer's disease. J. Neuropathol. Expt. Neurol. 39:1980;621-631.
81. Merz P.A., Wisniewski H.M., Somerville R.A., Bobin S.A., Masters C.L., Iqbal K. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. (Berl.). 60:1983;113-124.
82. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
83. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
84. Kamber B., Hartmann A., Eisler K., Riniker B., Rink H., Sieber P., Rittel W. The synthesis of cystine peptides by iodine oxidation of S-trityl-cysteine and S-acetamidomethyl-cysteine peptides. Helv. Chim. Acta. 63:1980;899-915.
85. Bodanszky M., Bodanszky A. 2nd edit. The Practice of Peptide Synthesis. 1994;Springer-Verlag, Berlin.
86. Chen S., Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10:2001;887-891.
87. Perkins S.J. Protein volumes and hydration effects. Eur. J. Biochem. 157:1986;169-180.
88. Philo J.S. An improved function for fitting sedimentation velocity data for low-molecular-weight solutes. Biophys. J. 72:1997;435-444.
89. Sreerama N., Venyaminov S.Y., Woody R.W. Estimation of the number of α-helical and β-strand segments in proteins using circular dichroism spectroscopy. Protein Sci. 8:1999;370-380.
90. Nichols M.R., Moss M.A., Reed D.K., Lin W.L., Mukhopadhyay R., Hoh J.H., Rosenberry T.L. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry. 41:2002;6115-6127.